This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Astrazeneca Ab, Hutchison Medipharma Limited. Active years: 2024.
Company Filing History:
1 out of 1,531 
1 out of 37 
Years Active: 2024
Title: Malcolm Allan Young Gall: Innovator in Pharmaceutical Manufacturing
Introduction
Malcolm Allan Young Gall is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical manufacturing, particularly through his innovative methods and formulations. His work has led to advancements in the production of complex chemical compounds.
Latest Patents
Malcolm Allan Young Gall holds a patent for a method titled "Method for the manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and polymorphic forms thereof." This specification generally relates to an improved method for the manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine (I), or pharmaceutically acceptable salts thereof; polymorphic forms thereof, and intermediates useful in the manufacture of such compounds and salts thereof. He has 1 patent to his name.
Career Highlights
Throughout his career, Malcolm has worked with prominent companies in the pharmaceutical industry. He has been associated with Hutchison Medipharma Limited and AstraZeneca AB, where he has contributed to various projects and innovations. His expertise in the field has made him a valuable asset to these organizations.
Collaborations
Malcolm has collaborated with several professionals in his field, including Andrew Turner and Neil Keith Adlington. These collaborations have further enhanced his work and contributed to the success of his projects.
Conclusion
Malcolm Allan Young Gall is a distinguished inventor whose work in pharmaceutical manufacturing has led to significant advancements in the industry. His innovative methods and collaborations with leading companies and professionals highlight his contributions to the field.